Sign in Subscribe
Diseases

Glycemic Variability Linked to Periodontitis in Patients with Type 2 Diabetes

Strategic Insights

— 2 min read

Patients with type 2 diabetes mellitus (T2DM) who experience significant fluctuations in blood sugar levels may be at a heightened risk of developing periodontitis, a severe gum disease that can cause tooth loss and other complications, according to a recent study published in the Clinical Oral Investigations journal. The research, conducted by a team of researchers from the Department of Stomatology at the Shenzhen Guangming District People's Hospital in Guangdong, People's Republic of China, analyzed data from 296 T2DM patients and found a strong correlation between glycemic variability and the presence and severity of periodontitis.

Key Takeaways:

  • The study found a significant correlation between glycemic variability and the presence and severity of periodontitis in patients with T2DM, with increased glycemic variability being associated with a higher risk of developing periodontitis.
  • The researchers screened 296 T2DM patients and categorized them into non-periodontitis and periodontitis groups, with 83 patients in the non-periodontitis group and 213 in the periodontitis group.
  • Periodontal status was categorized using American Academy of Periodontology guidelines into non-severe and severe groups, with 131 patients in the non-severe group and 82 in the severe group.
  • The study measured glycemic variability indices, including average blood glucose, coefficient of variation (CV), standard deviation (SD), and mean amplitude of glycemic excursions (MAGE), using continuous glucose monitoring systems.
  • The researchers quantified inflammatory markers, including interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-a), in gingival crevicular fluid (GCF) using enzyme-linked immunosorbent assay.
  • The study's findings underscore the importance of glycemic control in managing periodontal health in T2DM patients and suggest that glycemic variability may be a target for therapeutic interventions to mitigate the risk and progression of periodontitis.

Statistics:

  • The study included 296 T2DM patients, with 83 in the non-periodontitis group and 213 in the periodontitis group.
  • The researchers categorized periodontal status into non-severe and severe groups, with 131 patients in the non-severe group and 82 in the severe group.
  • The study measured glycemic variability indices, including average blood glucose, coefficient of variation (CV), standard deviation (SD), and mean amplitude of glycemic excursions (MAGE), using continuous glucose monitoring systems.
  • The researchers quantified inflammatory markers, including interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-a), in gingival crevicular fluid (GCF) using enzyme-linked immunosorbent assay.

Sources:

  • Analysis of the correlation between glycemic variability indices and disease severity as well as inflammatory status in patients with type 2 diabetes mellitus and periodontitis. Clinical Oral Investigations, 2025;29(11):508.
  • Clinical Oral Investigations can be contacted at: Springer Heidelberg, Tiergartenstrasse 17, D-69121 Heidelberg, Germany.
  • The publisher of the journal Clinical Oral Investigations can be contacted at: Springer Heidelberg, Tiergartenstrasse 17, D-69121 Heidelberg, Germany.
  • Keywords for this news article include: Asia, Guangdong, Biomarkers, Endocrinology, Periodontitis, Type 2 Diabetes, Membrane Proteins, Health and Medicine, Tumor Necrosis Factors, Diagnostics and Screening, People's Republic of China, Glucose Metabolism Disorders, Mouth Diseases and Conditions, Periodontal Diseases and Conditions.

Read more